- Home
- RNXT vs WWR Comparison
RNXT vs WWR Comparison
Compare RNXT & WWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- WWR
- Stock Information
- Founded
- RNXT 2012
- WWR 1977
- Country
- RNXT United States
- WWR United States
- Employees
- RNXT N/A
- WWR N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- WWR Metal Mining
- Sector
- RNXT Health Care
- WWR Basic Materials
- Exchange
- RNXT Nasdaq
- WWR Nasdaq
- Market Cap
- RNXT 44.6M
- WWR N/A
- IPO Year
- RNXT 2021
- WWR N/A
- Fundamental
- Price
- RNXT $1.36
- WWR $0.60
- Analyst Decision
- RNXT Strong Buy
- WWR Strong Buy
- Analyst Count
- RNXT 2
- WWR 1
- Target Price
- RNXT $7.25
- WWR $2.00
- AVG Volume (30 Days)
- RNXT 147.2K
- WWR 686.6K
- Earning Date
- RNXT 08-12-2025
- WWR 08-13-2025
- Dividend Yield
- RNXT N/A
- WWR N/A
- EPS Growth
- RNXT N/A
- WWR N/A
- EPS
- RNXT N/A
- WWR N/A
- Revenue
- RNXT $240,000.00
- WWR N/A
- Revenue This Year
- RNXT $3,186.05
- WWR N/A
- Revenue Next Year
- RNXT $291.93
- WWR N/A
- P/E Ratio
- RNXT N/A
- WWR N/A
- Revenue Growth
- RNXT N/A
- WWR N/A
- 52 Week Low
- RNXT $0.75
- WWR $0.45
- 52 Week High
- RNXT $1.69
- WWR $1.32
- Technical
- Relative Strength Index (RSI)
- RNXT 49.29
- WWR 56.02
- Support Level
- RNXT $1.27
- WWR $0.59
- Resistance Level
- RNXT $1.42
- WWR $0.66
- Average True Range (ATR)
- RNXT 0.06
- WWR 0.04
- MACD
- RNXT -0.02
- WWR -0.00
- Stochastic Oscillator
- RNXT 25.06
- WWR 50.00
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.